Industry

In this short video, Tracy Weslosky of InvestorIntel interviews Chris Thompson of eResearch about eResearch’s Update Report on DCM pertaining to the Company’s recent release of its Q3/2021 financial statements that had adjusted EBITDA at $9.4M. [more]

We have written a 44-page Initiation Report on Datable Technology Corporation, a Canadian-based software development and technology company operating in the consumer online advertising and marketing sectors. Datable offers a SaaS-based Consumer Lifecycle and Data Management Platform called PLATFORM³ that enables CPG companies and consumer brands to build and launch promotions, special offers, and loyalty programs on mobile phones, websites, and microsites. Datable recently announced the acquisition of Dabbl that creates a combined company expected to have 2021 pro-forma revenue of almost $6 million. We are Initiating Coverage on Datable with a Speculative Buy rating and one-year price target of $0.30/share. [more]

We have written a 45-page Initiation Report on Silver Bullet Mines, a Canadian-based silver and copper exploration and development company that recently went public and raised over $6 million. SBMI’s main asset is the Black Diamond Property near Globe, Arizona, with silver and copper-gold porphyry projects. Near-term cash flow de-risks the project as work is already underway to get the Buckeye Mine back into production. We are Initiating Coverage with a Speculative Buy rating and one-year price target of $0.80. [more]

We review different companies that compose the industry: the trends, issues, challenges, and their strategies. For this first edition, we will just provide an overview of the key points. Our ultimate goal is to identify companies and products that may have a strategic advantage in competing in this transforming industry.
[more]

We have written a 19-page Update Report on DCM. The communications and marketing solutions provider continues its “Digital-First” strategy and leveraging its existing platforms for direct-to-print applications, marketing and workflow management, and DAM solutions. Revenue was $56.9M, up 3.1% from $55.2M in Q2/2021. Adjusted EBITDA was $9.4M and improved cash flow reduced debt in the quarter by $2.8M. We are maintaining a Buy rating and increasing the one-year price target to $3.75/share from $3.60/share. [more]

In this short video, Tracy Weslosky of InvestorIntel interviews Chris Thompson of eResearch about eResearch’s Update Report on Xortx Therapeutics pertaining to the Company’s recent $21 million financing and U.S. listing. [more]

New 25-page Update Equity Research Report on XORTX, with a Buy rating and one-year price target of $26.00/share. The Company has two potential late-stage drugs in development focused on kidney diseases with one drug that could be approved within the next 18 months and the other drug that could have an orphan drug indication on the market in 2025. [more]

This is an update article to the original “Chart of the Day” report on Suncor from September 20, 2021. Suncor’s stock price is up 19% in 3 weeks. [more]